Key Metrics
CiteScore 

4
H-Index 

103
Impact Factor 

< 5
SJR 

Q3Pharmacology

SNIP 

0.61
Recommended pre-submission checks
Powered by 

Topics Covered on Anti-Cancer Agents in Medicinal Chemistry
Anti-Cancer Agents in Medicinal Chemistry Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Anti-Cancer Agents in Medicinal Chemistry ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Anti-Cancer Agents in Medicinal Chemistry
Dendritic Cell Vaccines for Glioblastoma: A Systematic Review and Meta-Analysis Comparing New-Onset and Recurrent Cases.
- 27 Jul 2026
- Anti-cancer agents in medicinal chemistry
Rechallenge Therapy: New Dimensions in Cancer Therapy.
- 23 Jul 2026
- Anti-cancer agents in medicinal chemistry
Emrelis for c-Met Positive NSCLC: A Breakthrough in Antibody-Drug Conjugate-based Treatment Approved by the FDA.
- 23 Jul 2026
- Anti-cancer agents in medicinal chemistry
Lazertinib: A Selective EGFR Mutant Inhibitor to Treat Non-Small Cell Lung Cancer.
- 23 Jul 2026
- Anti-cancer agents in medicinal chemistry
CDK4/6-Based Drug Research and Development: A Four-Year Update.
- 21 Jul 2026
- Anti-cancer agents in medicinal chemistry
CD147 Is Involved in Tanshinone IIA-Induced Reprogramming of the Warburg Effect in Prostate Cancer Cells.
- 21 Jul 2026
- Anti-cancer agents in medicinal chemistry
Dendritic Cell Vaccines for Glioblastoma: A Systematic Review and Meta-Analysis Comparing New-Onset and Recurrent Cases.
- 27 Jul 2026
- Anti-cancer agents in medicinal chemistry
Rechallenge Therapy: New Dimensions in Cancer Therapy.
- 23 Jul 2026
- Anti-cancer agents in medicinal chemistry
Emrelis for c-Met Positive NSCLC: A Breakthrough in Antibody-Drug Conjugate-based Treatment Approved by the FDA.
- 23 Jul 2026
- Anti-cancer agents in medicinal chemistry
Lazertinib: A Selective EGFR Mutant Inhibitor to Treat Non-Small Cell Lung Cancer.
- 23 Jul 2026
- Anti-cancer agents in medicinal chemistry
CDK4/6-Based Drug Research and Development: A Four-Year Update.
- 21 Jul 2026
- Anti-cancer agents in medicinal chemistry
CD147 Is Involved in Tanshinone IIA-Induced Reprogramming of the Warburg Effect in Prostate Cancer Cells.
- 21 Jul 2026
- Anti-cancer agents in medicinal chemistry